cancer biosimilars

Views & Analysis

Adrian van den Hoven of Medicines for Europe addresses three big questions facing the biosmilars sector in Europe in 2018.

News

ITM's first attempt to score FDA approval for one of its radiopharma therapies has been knocked back by the agency.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.